TTM
$33.33B
YoY change
+18.8%
5Y CAGR
+8.5%
Peak year (2025)
$32.60B
Cumulative gross profit
$569.64B
Gross Profit history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Latest: $32.60B
Gross Profit growth chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Latest: +18.8%
Gross Profit history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| 2025 | $32.60B | +18.8% | +$5.17B | ||
| 2024 | $27.43B | +8.2% | +$2.08B | ||
| 2023 | $25.36B | -4.3% | −$1.13B | ||
| 2022 | $26.49B | -1.0% | −$271.00M | ||
| 2021 | $26.76B | +23.3% | +$5.06B | ||
| 2020 | $21.70B | +25.8% | +$4.45B | ||
| 2019 | $17.25B | +7.3% | +$1.18B | ||
| 2018 | $16.07B | +7.5% | +$1.12B | ||
| 2017 | $14.96B | +3.2% | +$463.00M | ||
| 2016 | $14.49B | +13.2% | +$1.69B | ||
| 2015 | $12.81B | +6.7% | +$806.00M | ||
| 2014 | $12.00B | +1.7% | +$200.00M | ||
| 2013 | $11.80B | -10.5% | −$1.39B | ||
| 2012 | $13.19B | -16.1% | −$2.53B | ||
| 2011 | $15.72B | +9.7% | +$1.39B | ||
| 2010 | $14.33B | +4.0% | +$553.00M | ||
| 2009 | $13.78B | -4.6% | −$664.00M | ||
| 2008 | $14.44B | +9.3% | +$1.23B | ||
| 2007 | $13.21B | +13.0% | +$1.52B | ||
| 2006 | $11.68B | -12.7% | −$1.70B | ||
| 2005 | $13.38B | -1.4% | −$187.00M | ||
| 2004 | $13.57B | +2.0% | +$266.00M | ||
| 2003 | $13.30B | +13.4% | +$1.57B | ||
| 2002 | $11.73B | -15.3% | −$2.12B | ||
| 2001 | $13.85B | -2.5% | −$355.00M | ||
| 2000 | $14.20B | -7.5% | −$1.16B | ||
| 1999 | $15.36B | +9.3% | +$1.31B | ||
| 1998 | $14.05B | +9.5% | +$1.23B | ||
| 1997 | $12.83B | +10.4% | +$1.21B | ||
| 1996 | $11.62B | +9.8% | +$1.04B | ||
| 1995 | $10.58B | +15.1% | +$1.39B | ||
| 1994 | $9.19B | +5.7% | +$498.00M | ||
| 1993 | $8.69B | +1.1% | +$98.00M | ||
| 1992 | $8.59B | +1.4% | +$119.00M | ||
| 1991 | $8.47B | +10.5% | +$805.00M | ||
| 1990 | $7.67B | +14.0% | +$941.00M | ||
| 1989 | $6.73B | +7.5% | +$470.00M | ||
| 1988 | $6.26B | +15.5% | +$842.00M | ||
| 1987 | $5.42B | — | — |
- 2025$32.60B+18.8%
- 2024$27.43B+8.2%
- 2023$25.36B-4.3%
- 2022$26.49B-1.0%
- 2021$26.76B+23.3%
- 2020$21.70B+25.8%
- 2019$17.25B+7.3%
- 2018$16.07B+7.5%
- 2017$14.96B+3.2%
- 2016$14.49B+13.2%
- 2015$12.81B+6.7%
- 2014$12.00B+1.7%
- 2013$11.80B-10.5%
- 2012$13.19B-16.1%
- 2011$15.72B+9.7%
- 2010$14.33B+4.0%
- 2009$13.78B-4.6%
- 2008$14.44B+9.3%
- 2007$13.21B+13.0%
- 2006$11.68B-12.7%
- 2005$13.38B-1.4%
- 2004$13.57B+2.0%
- 2003$13.30B+13.4%
- 2002$11.73B-15.3%
- 2001$13.85B-2.5%
- 2000$14.20B-7.5%
- 1999$15.36B+9.3%
- 1998$14.05B+9.5%
- 1997$12.83B+10.4%
- 1996$11.62B+9.8%
- 1995$10.58B+15.1%
- 1994$9.19B+5.7%
- 1993$8.69B+1.1%
- 1992$8.59B+1.4%
- 1991$8.47B+10.5%
- 1990$7.67B+14.0%
- 1989$6.73B+7.5%
- 1988$6.26B+15.5%
- 1987$5.42B—
Gross Profit values are taken from Bristol-Myers Squibb's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's current gross profit (TTM) is $33.33B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Bristol-Myers Squibb (BMY) most recent annual gross profit stands at $32.60B (2025) – grew 18.8% year-over-year.
Bristol-Myers Squibb gross profit has grown for 2 consecutive years, with a +8.5% compound annual growth rate over 2020–2025 (5 years).
Across the available history, gross profit reached its high of $32.60B in 2025 and its low of $5.42B in 1987.
Bristol-Myers Squibb Gross Profit by Year
Bristol-Myers Squibb Gross Profit 2025: $32.60B
Bristol-Myers Squibb gross profit in 2025 was $32.60B, grew 18.8% from 2024. This figure represents the highest annual value in the available history.
Bristol-Myers Squibb Gross Profit 2024: $27.43B
2024's gross profit for Bristol-Myers Squibb came in at $27.43B, grew 8.2% from 2023.
Bristol-Myers Squibb Gross Profit 2023: $25.36B
Bristol-Myers Squibb posted gross profit of $25.36B in 2023, edged down 4.3% below 2022.
Bristol-Myers Squibb Gross Profit 2022: $26.49B
In 2022, Bristol-Myers Squibb reported gross profit of $26.49B, edged down 1.0% below 2021.
Bristol-Myers Squibb Gross Profit 2021: $26.76B
Bristol-Myers Squibb gross profit in 2021 was $26.76B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers by Gross Profit
Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation